» Articles » PMID: 35296074

APE1/Ref-1 Role in Inflammation and Immune Response

Abstract

Apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1) is a multifunctional enzyme that is essential for maintaining cellular homeostasis. APE1 is the major apurinic/apyrimidinic endonuclease in the base excision repair pathway and acts as a redox-dependent regulator of several transcription factors, including NF-κB, AP-1, HIF-1α, and STAT3. These functions render APE1 vital to regulating cell signaling, senescence, and inflammatory pathways. In addition to regulating cytokine and chemokine expression through activation of redox sensitive transcription factors, APE1 participates in other critical processes in the immune response, including production of reactive oxygen species and class switch recombination. Furthermore, through participation in active chromatin demethylation, the repair function of APE1 also regulates transcription of some genes, including cytokines such as TNFα. The multiple functions of APE1 make it an essential regulator of the pathogenesis of several diseases, including cancer and neurological disorders. Therefore, APE1 inhibitors have therapeutic potential. APE1 is highly expressed in the central nervous system (CNS) and participates in tissue homeostasis, and its roles in neurodegenerative and neuroinflammatory diseases have been elucidated. This review discusses known roles of APE1 in innate and adaptive immunity, especially in the CNS, recent evidence of a role in the extracellular environment, and the therapeutic potential of APE1 inhibitors in infectious/immune diseases.

Citing Articles

Hypoxia-inducible factor and cellular senescence in pulmonary aging and disease.

Thapa R, Marianesan A, Rekha A, Ganesan S, Kumari M, Bhat A Biogerontology. 2025; 26(2):64.

PMID: 40011266 PMC: 11865175. DOI: 10.1007/s10522-025-10208-z.


Forsythia suspensa leaf fermented tea extracts attenuated oxidative stress in mice via the Ref-1/HIF-1α signal pathway and modulation of gut microbiota.

Li L, Zhao Y, Ding Y, Guo L, Dai R, Chen A Sci Rep. 2025; 15(1):4106.

PMID: 39900709 PMC: 11790883. DOI: 10.1038/s41598-025-87182-6.


Serum proteome profiling of plateau acclimatization in men using Olink proteomics approach.

Pan J, Dong Y, Zou Z, Gu T, Chen L, Li K Physiol Rep. 2024; 12(24):e70091.

PMID: 39725655 PMC: 11671244. DOI: 10.14814/phy2.70091.


Pleiotropic Effects of Resveratrol on Aging-Related Cardiovascular Diseases-What Can We Learn from Research in Dogs?.

Grzeczka A, Graczyk S, Kordowitzki P Cells. 2024; 13(20.

PMID: 39451250 PMC: 11505706. DOI: 10.3390/cells13201732.


Role of APE1 in hepatocellular carcinoma and its prospects as a target in clinical settings (Review).

Yang L, Sun Z Mol Clin Oncol. 2024; 21(5):82.

PMID: 39301126 PMC: 11411593. DOI: 10.3892/mco.2024.2780.


References
1.
Lee Y, Joo H, Lee E, Park M, Cho H, Kim S . Plasma APE1/Ref-1 Correlates with Atherosclerotic Inflammation in ApoE Mice. Biomedicines. 2020; 8(9). PMC: 7555038. DOI: 10.3390/biomedicines8090366. View

2.
Aviello G, Knaus U . NADPH oxidases and ROS signaling in the gastrointestinal tract. Mucosal Immunol. 2018; 11(4):1011-1023. DOI: 10.1038/s41385-018-0021-8. View

3.
Guo Y, Chen J, Zhao T, Fan Z . Granzyme K degrades the redox/DNA repair enzyme Ape1 to trigger oxidative stress of target cells leading to cytotoxicity. Mol Immunol. 2008; 45(8):2225-35. DOI: 10.1016/j.molimm.2007.11.020. View

4.
Miyamoto K, Nagakawa J, Hishinuma I, Hirota K, Yasuda M, Yamanaka T . Suppressive effects of E3330, a novel quinone derivative, on tumor necrosis factor-alpha generation from monocytes and macrophages. Agents Actions. 1992; 37(3-4):297-304. DOI: 10.1007/BF02028123. View

5.
Hinz J, Mao P, McNeill D, Wilson 3rd D . Reduced Nuclease Activity of Apurinic/Apyrimidinic Endonuclease (APE1) Variants on Nucleosomes: IDENTIFICATION OF ACCESS RESIDUES. J Biol Chem. 2015; 290(34):21067-21075. PMC: 4543664. DOI: 10.1074/jbc.M115.665547. View